StockData
CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc. (CASIF) stock

CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 1/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

CASI Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

CASI Pharmaceuticals's price to book ratio was 8.5× on Jan 30, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 0.3× to 19.3×, with a median of 1.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 20268.5×+1.4
2025Dec 31, 20257.1×+5.5
2024Dec 31, 20241.6×−0.6
2023Dec 29, 20232.2×+1.9
2022Dec 30, 20220.3×−0.8
2021Dec 31, 20211.1×–

More CASI Pharmaceuticals figures

See a number that looks wrong?